M&A Deal Summary

Alira Health Acquires CROS NT

On June 8, 2021, Alira Health acquired life science company CROS NT

Acquisition Highlights
  • This is Alira Health’s 2nd transaction in the Life Science sector.
  • This is Alira Health’s 1st transaction in Italy.

M&A Deal Summary

Date 2021-06-08
Target CROS NT
Sector Life Science
Buyer(s) Alira Health
Deal Type Add-on Acquisition

Target

CROS NT

Verona, Italy
CROS NT is a data-driven Contract Research Organization (CRO) providing services from feasibility to clinical study reporting for Phases I-IV and medical device trials. CROS NT's services include regulatory consultancy, monitoring, data management, biostatistics programming & analysis, pharmacovigilance and medical writing, and accompanying eClinical applications (data visualization, EDC, IWRS, eCOA/ePRO etc.). CROS NT was founded in 1992 and is based in Verona, Italy.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Alira Health

Framingham, Massachusetts, United States

Category Company
Founded 1999
Sector Business Services
DESCRIPTION

Alira Health is a provider of an integrated strategy, execution and innovation services to help businesses bring pharma, medical technology and healthcare IT to market.


DEAL STATS #
Overall 5 of 11
Sector (Life Science) 2 of 3
Type (Add-on Acquisition) 5 of 11
Country (Italy) 1 of 2
Year (2021) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-07 Chamow & Associates

San Mateo , California, United States

Chamow & Associates is a biopharmaceutical consulting company. The Company provides integrated CMC services, including molecular engineering, process development and manufacturing, quality, regulatory, and project management services, to clinical-stage biotechnology companies around the world. Chamow and Associates focuses on monoclonal antibodies and derivatives, including bispecific antibodies and antibody drug conjugates, in addition to other recombinant protein products. Chamow & Associates was founded in 2008 and is based in San Mateo, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-28 BePatient

Paris, France

BePatient is a healthcare technology company that offers ‘real life’ digital patient data capture solutions for large pharmaceutical manufacturers, medical technology companies, associations, and public institutions. The company provides clinical solutions for virtual trials and Real-World Evidence (RWE) as well as digital therapeutics for prevention and care management. Its portfolio of solutions is structured around two activities: clinical research digitalization via direct-to-patient virtual trials technologies and digital therapeutics. BePatient is based in Paris, France.

Buy -